Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Infant, Newborn: full-pipeline trial registry

5 of 15 indexed Infant, Newborn trials are currently recruiting.

Corpus placement: #1,140 of 28,707 conditions by registered trial count.

15 US clinical trials · 5 currently recruiting · #1,140 of 28,707 conditions by registered trial count

Infant, Newborn: 15 US clinical trials tracked, 5 recruiting.

Infant, Newborn is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is NICHD Neonatal Research Network, running 11 of these trials.

Enrollment posture brief

Registry condition infant-newborn

OPEN 5 | RECR 33% | LATE 2 | EARLY 2 | RANK #1140 | SPON 11

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Advanced Lung Non-Small Cell53.3%Infant, Newborn (this)33%AIDS26.7%Adult Acute Myeloid Leukemia0%Adult Glioblastoma0%
Open-enrollment share among volume-matched conditions near Infant, Newborn

Infant, Newborn lists 5 open slots (33% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Infant, Newborn on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Infant, Newborn is recruiting below its size-band peers.

    5 of 15 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Infant, Newborn research.

    NICHD Neonatal Research Network accounts for 11 of 15 trials (73.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Infant, Newborn enrolment sits around 1,339 participants.

    Median target enrolment is 1,339 among the 15 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Infant, Newborn splits between interventional and observational designs.

    7 interventional and 8 observational studies make up this index (46.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 32

Open and recent trials

15 total, page 1 of 1

RECRUITING 3,000,000 participants

Delivery Room Intervention and Evaluation Network

American Academy of Pediatrics

NCT06803498

RECRUITING 80,000 participants

Generic Database of Very Low Birth Weight Infants

NICHD Neonatal Research Network

NCT00063063

RECRUITING 68,000 participants

Follow-up Visit of High Risk Infants

NICHD Neonatal Research Network

NCT00009633

RECRUITING NA 36,503 participants

Supraglottic Airway for Resuscitation Trial

Children's Hospital of Philadelphia

NCT07150923

RECRUITING NA 2,400 participants

Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children

Stanford University

NCT07261254

COMPLETED Phase 2 2,416 participants

Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

NICHD Neonatal Research Network

NCT01203345

COMPLETED Phase 3 1,433 participants

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants

NICHD Neonatal Research Network

NCT00005775

COMPLETED 1,339 participants

In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants

NICHD Neonatal Research Network

NCT01203501

COMPLETED 1,090 participants

Development of Standards for the New Ballard Maturation Score

NICHD Neonatal Research Network

NCT01203449

COMPLETED 1,067 participants

Inflammatory Cytokines Associated With Perinatal Brain Injury

NICHD Neonatal Research Network

NCT01035697

COMPLETED Phase 3 800 participants

Hydrocortisone for BPD

NICHD Neonatal Research Network

NCT01353313

COMPLETED 410 participants

Physiologic Definition of Bronchopulmonary Dysplasia

NICHD Neonatal Research Network

NCT01223287

COMPLETED NA 226 participants

Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates

University of Texas Southwestern Medical Center

NCT02064712

COMPLETED Phase 1 104 participants

Delivery Room CPAP in Extremely Low Birth Weight Infants

NICHD Neonatal Research Network

NCT01223274

COMPLETED 102 participants

Cerebral Function Monitoring in Premature Infants

NICHD Neonatal Research Network

NCT00873847

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2

Named interventions

Most-linked intervention names on Infant, Newborn records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
No Intervention Other
2 trials
High CPAP Wean Other
1 trials
Low CPAP Wean Other
1 trials
Standard management practices Device
1 trials
CPAP/PEEP Device
1 trials
Glutamine Drug
1 trials
IVIG Drug
1 trials

US sites by state

Facility locations filed on Infant, Newborn trials. A trial with sites in several states counts in each.

California 12 trials
Michigan 10 trials
Alabama 10 trials
Texas 9 trials
Indiana 9 trials
Georgia 9 trials
Ohio 8 trials
New Mexico 8 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Infant, Newborn page

15 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infant, Newborn condition card totals 15 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.